US market for analytical microchip technologies in the life sciences is poised to experience explosive growth in the next five years
According to a new market research study from Kalorama Information, the US market for analytical microchip technologies in the life sciences is poised to experience explosive growth in the next five years, with some segments expected to see triple-digit annual growth through 2009.
The new study, US markets in analytical chip technology, 2nd edition, found that current market potential in the industry is approximately US$2 billion - the majority of which is in the DNA/gene microarray segment.
However, protein microarrays and microbiology microarrays are becoming more prominent, and the market for tissue microarrays and analytical process chips are forecast to explode in the next ten years.
"There is little doubt that these technologies will be enormously important and the market will expand," notes Kenneth Krul, author of the report.
"The real questions for the industry are 'How fast will the market expand?' and perhaps more important, 'When will the expansion take place?'".
The current study is the second time Kalorama Information has investigated the analytical chip market in depth.
This complete update to the 2002 study re-evaluates and extends the forecasts through 2014 for five microchip segments: DNA/gene, protein, tissue, cell, and microbiology microarrays.
In addition, it adds a new segment, analytical process chips.
In addition to a thorough market analysis, the 480-page report details technology development, applications, and progress toward commercialisation in each of the segments.
The report also provides in-depth profiles of 15 top competitors in the field and eight high-level conclusions, and their strategic implications for developers are discussed.
Priced at $3500, US markets in analytical chip technology 2nd edition can be purchased directly from Kalorama Information.
